Search Count: 119
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-06-17 Classification: CELL CYCLE |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2020-06-17 Classification: CELL CYCLE Ligands: LCW |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2020-06-17 Classification: CELL CYCLE Ligands: LCB, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-06-17 Classification: CELL CYCLE Ligands: LCQ |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2016-11-23 Classification: TRANSFERASE Ligands: 4SP |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2016-11-09 Classification: Transferase/Inhibitor Ligands: NU6 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2016-11-09 Classification: Transferase/Inhibitor Ligands: 7GJ, PEG, EDO, PO4 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2016-11-02 Classification: TRANSFERASE Ligands: 7GG, SO4, CL |
![]() |
Multi-Parameter Lead Optimization To Give An Oral Chk1 Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-Ylmethyl)Amino)-5-(Trifluoromethyl)Pyridin-2-Yl)Amino)Pyrazine-2-Carbonitrile (Cct245737)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2016-05-25 Classification: TRANSFERASE Ligands: 5UY, EDO, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5TZ, EDO, DMS, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-01-20 Classification: Oxidoreductase/Inhibitor Ligands: ZN, 5UP, EDO, DMS |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5V7, DMS, EDO, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.22 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, N5J, EDO, DMS |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5UB, DMS |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5U8, DMS, GOL, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5UO, DMS, GOL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5UL, DMS, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, 5UJ, DMS, GOL, CL |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2016-01-20 Classification: OXIDOREDUCTASE Ligands: ZN, MN, QAY, EDO, DMS |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2015-12-30 Classification: OXIDOREDUCTASE Ligands: ZN, NI, EDO, SO4, 5V3 |